Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex A Adjei

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Methods in Molecular Medicine|April 25, 2003
Immunohistochemical assays of farnesyltransferase inhibition in patient samplesAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
Lung Cancer WorldwideAlex A Adjei
Clinical Lung Cancer|March 27, 2007
Novel small-molecule inhibitors of the vascular endothelial growth factor receptorAlex A Adjei
Clinical Lung Cancer|October 28, 2005
Sequencing bortezomib with chemotherapy and targeted agentsAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2013
Lung cancer-celebrating progress and acknowledging challengesAlex A Adjei
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
An overview of farnesyltransferase inhibitors and their role in lung cancer therapyAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2018
2017-A Banner Year for Thoracic OncologyAlex A Adjei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
What is the right dose? The elusive optimal biologic dose in phase I clinical trialsAlex A Adjei
Clinical Lung Cancer|December 5, 2003
"Targeted" therapies for non-small cell lung cancerAlex A Adjei
Clinical Lung Cancer|January 15, 2004
Current data with pemetrexed (Alimta) in non-small-cell lung cancerAlex A Adjei
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Methods in Molecular Medicine|April 25, 2003
Immunohistochemical assays of farnesyltransferase inhibition in patient samplesAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
Lung Cancer WorldwideAlex A Adjei
Clinical Lung Cancer|March 27, 2007
Novel small-molecule inhibitors of the vascular endothelial growth factor receptorAlex A Adjei
Clinical Lung Cancer|October 28, 2005
Sequencing bortezomib with chemotherapy and targeted agentsAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2013
Lung cancer-celebrating progress and acknowledging challengesAlex A Adjei
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
An overview of farnesyltransferase inhibitors and their role in lung cancer therapyAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2018
2017-A Banner Year for Thoracic OncologyAlex A Adjei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
What is the right dose? The elusive optimal biologic dose in phase I clinical trialsAlex A Adjei
Clinical Lung Cancer|December 5, 2003
"Targeted" therapies for non-small cell lung cancerAlex A Adjei
Clinical Lung Cancer|January 15, 2004
Current data with pemetrexed (Alimta) in non-small-cell lung cancerAlex A Adjei
Pageof 29